Febuxostat: a new drug for an old disease. Do we really need it?
BACKGROUND Febuxostat is a non-purine selective inhibitor of xanthine oxidase whose therapeutic effect is decreasing the serum uric acid concentration. Febuxostat has a marketing authorisation for the treatment of chronic hyperuricaemia in conditions where urate/uric acid deposition has already occu...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2013-04-01
|
Series: | Italian Journal of Medicine |
Subjects: | |
Online Access: | http://www.italjmed.org/index.php/ijm/article/view/261 |